Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Mar 14;2012(3):CD005544.
doi: 10.1002/14651858.CD005544.pub2.

Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infants

Timothy J Donovan  1 , Kerry Buchanan
Affiliations
Meta-Analysis

Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infants

Timothy J Donovan et al. Cochrane Database Syst Rev. .

Abstract

Background: Breastmilk remains the optimal form of enteral nutrition for term and preterm infants until up to six months postnatal age. Mothers of preterm infants who have not established suck feeds must express their breastmilk and often have difficulty in maintaining sufficient volume for their infants' needs (Donath 2008). In preterm infants, donor breastmilk reduced the occurrence of necrotising enterocolitis, when compared with formula feeds (McGuire 2003). Also, case-control studies have suggested that breastmilk is associated with an improvement in feeding tolerance, a reduction in significant gastrointestinal infective events (Beeby 1992) and a reduction in late-onset sepsis (Schanler 1999) when compared with formula feeds in preterm hospitalised infants.

Objectives: To assess the effect of medication given for at least seven days to mothers of preterm infants whose breastmilk is insufficient for their infants' needs on the outcomes of expressed milk volume and duration of breastfeeding.

Search methods: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 December 2011).

Selection criteria: Randomised and quasi-randomised controlled trials of breastmilk-augmenting medications (compared with placebo or with other augmenting medications) in mothers with preterm hospitalised infants whose breastmilk volumes failed to meet their infants' requirements. We did not include trials with a cluster-randomised or cross-over design.

Data collection and analysis: Both review authors independently assessed studies for inclusion, assessed risk of bias, and extracted data. Any differences were resolved by consensus. Data were checked for accuracy.

Main results: Two trials (involving 59 mothers) that examined the use of domperidone in a total of 59 mother-infant pairs met the inclusion criteria. Meta-analysis of these trials showed a modest increase in expressed breastmilk (EBM) of 99.49 mL/day (95% confidence intervals -1.94 to 200.92; random-effects, T² 3511.62, I² 63%) in mothers given domperidone. Both trials gave the same dose of domperidone (10 mg three times per day) with a duration of seven days in the smaller trial and 14 days in the larger.Neither trial showed significant improvements in longer-term outcomes of breastfeeding in a preterm population and no adverse effects were reported.

Authors' conclusions: Two studies with a total of 59 mothers suggest modest improvements in short-term EBM volumes when a medication is used after insufficient EBM occurs in mothers following preterm delivery. In both studies, the medication was commenced ≧14 days post delivery and following insufficient EBM supply with other lactation supports.Currently, no studies support prophylactic use of a galactagogue medication at any gestation. Use of any galactagogue medication has only been examined at more than 14 days post delivery and after full lactation support has been given. Further trials should examine larger groups of preterm mothers and consider breastfeeding outcomes over a longer period.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1.1
1.1. Analysis
Comparison 1 Domperidone versus placebo, Outcome 1 Difference in volume of EBM per day.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD005544

References

References to studies included in this review

Campbell‐Yeo 2010 {published data only}
    1. Campbell‐Yeo ML, Allen AC, Joseph KS, Ledwidge JM, Allen VM, Dooley KC. Study protocol: a double blind placebo controlled trial examining the effect of domperidone on the composition of breast milk. BMC Pregnancy and Childbirth 2006;6:17. - PMC - PubMed
    1. Campbell‐Yeo ML, Allen AC, Joseph KS, Ledwidge PD, Caddell K, Allen VM, et al. Effect of domperidone on the composition of preterm human breast milk. Pediatrics 2010;125(1):e107‐e114. - PubMed
Silva 2001 {published data only (unpublished sought but not used)}
    1. Silva OP, Knoppert DC, Angelini MM, Forret PA. Effect of domperidone on milk production in mothers of premature newborns: a randomized, double‐blind, placebo‐controlled trial. CMAJ: Canadian Medical Association Journal 2001;164(1):17‐21. - PMC - PubMed

References to studies excluded from this review

Chong 2006 {unpublished data only}
    1. Chong YS, Mattar C. Metoclopramide to improve lactogenesis II in diabetic women: a randomized controlled trial. http://clinicaltrials.gov/ct2/show/record/NCT00477776 (accessed 29 November 2011).
Ehrenkranz 1987a {published data only (unpublished sought but not used)}
    1. Ehrenkranz RA, Ackerman BA, Sherwonit EA, Williams JE. Metoclopramide (MC) support of lactation: randomized, placebo‐controlled, cross‐over trial in mothers of premature infants. Pediatric Research 1987;21:427A.
Ehrenkranz 1987b {published data only}
    1. Ehrenkranz RA, Ackerman BA, Sherwonit EA, Williams JE. Serum prolactin (PRL) levels and lactation in mothers of premature infants. Pediatric Research 1987;21:427A.
Fewtrell 2006 {published data only}
    1. Fewtrell MS, Loh KL, Blake A, Ridout DA, Hawdon J. Randomised, double blind trial of oxytocin nasal spray in mothers expressing breast milk for preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2006;91(3):F169‐F174. - PMC - PubMed
Gunn 1996 {published data only}
    1. Gunn AJ, Gunn TR, Rabone DL, Breier BH, Blum WF, Gluckman PD. Growth hormone increases breast milk volumes in mothers of preterm infants. Pediatrics 1996;98(2 Pt 1):279‐82. - PubMed
Hansen 2005 {published data only}
    1. Hansen WF, McAndrew S, Harris K, Zimmerman MB. Metoclopramide effect on breastfeeding the preterm infant: a randomized trial. Obstetrics & Gynecology 2005;105:383‐9. - PubMed
Hofmeyr 1985 {published data only}
    1. Hofmeyr GJ, Iddekinge B, Blott JA. Domperidone: secretion in breast milk and effect on puerperal prolactin levels. British Journal of Obstetrics and Gynaecology 1985;92:141‐4. - PubMed
James 2004 {unpublished data only}
    1. James S. A double blind randomised controlled trial of domperidone and metoclopramide as pro‐lactational agents in mothers of preterm infants. Perinatal Trials Report (http://www.ctc.usyd.edu.au/6registry/PTO392.htm) (accessed 7 April 2004).
Kauppila 1981 {published data only}
    1. Kauppila A, Kivinen S, Ylikorkala O. A dose response relation between improved lactation and metoclopramide. Lancet 1981;1:1175‐7. - PubMed
Lewis 1980 {published data only}
    1. Lewis PJ, Devenish C, Kahn C. Controlled trial of metoclopramide in the initiation of breast feeding. British Journal of Clinical Pharmacology 1980;9:217‐9. - PMC - PubMed
Loh 2007 {unpublished data only}
    1. Loh D. Metoclopramide to aid establishment of breastfeeding: a randomised controlled trial. Current Controlled Trials (www.controlled‐trials.com) Unpublished (accessed 23 November 2010).
Mersmann 1996 {published data only}
    1. Mersmann CA. Therapeutic touch and milk letdown in mothers of non‐nursing preterm infants [dissertation]. New York University, 1996.
Powe 2011 {published data only}
    1. Powe CE, Puopolo KM, Newburg DS, Lonnerdal B, Chen C, Allen M, et al. Effects of recombinant human prolactin on breast milk composition. Pediatrics 2011;127(2):e359‐e366. - PMC - PubMed
Ruis 1981 {published data only}
    1. Ruis H, Rolland R, Doesburg W, Broeders G, Corbey R. Oxytocin enhances onset of lactation among mothers delivering prematurely. BMJ. Clinical Research Edition 1981;283:340‐2. - PMC - PubMed
Wan 2008 {published data only}
    1. Wan EW, Davey K, Page‐Sharp M, Hartmann PE, Simmer K, Ilett KF. Dose‐effect study of domperidone as a galactagogue in preterm mothers with insufficient milk supply, and its transfer into milk. British Journal of Clinical Pharmacology 2008;66(2):283‐9. - PMC - PubMed

References to studies awaiting assessment

Powe 2010 {published data only}
    1. Powe CE, Allen M, Puopolo KM, Merewood A, Worden S, Johnson LC, et al. Recombinant human prolactin for the treatment of lactation insufficiency. Clinical Endocrinology 2010;73(5):645‐53. - PMC - PubMed

Additional references

ABS 2003
    1. Australian Bureau of Statistics. Breastfeeding in Australia. http:www.abs.gov.au/austats/abs@nfs/ (accessed 14 October 2003).
Beeby 1992
    1. Beeby PJ, Jeffery H. Risk factors for necrotising enterocolitis: the influence of gestational age. Archives of Diseases of Childhood 1992;67:432‐5. - PMC - PubMed
Brodribb 1998
    1. Bodribb W. Breastfeeding Management in Australia. Victoria: Merrily Merrily Enterprises, 1998.
Donath 2008
    1. Donath S, Amir L. Effect of gestation on initiation and duration of breastfeeding. Archives of Diseases of Childhood: Fetal and Neonatal Edition 2008;93(6):F448‐F450. - PubMed
Dyson 2005
    1. Dyson L, McCormick F, Renfrew MJ. Interventions for promoting the initiation of breastfeeding. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001688.pub2] - DOI - PubMed
Egger 1997
    1. Egger M, Smith GD, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315:629‐34. - PMC - PubMed
Fischer 1998
    1. Fischer H, Gottschlich R, Seel A. Blood brain barrier permeation: molecular parameters governing passive diffusion. Journal of Membrane Biology 1998;165:201‐11. - PubMed
Harbord 2006
    1. Harbord RM, Egger M, Sterne JA. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443‐57. - PubMed
Higgins 2011
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hylander 1998
    1. Hylander M, Strobino D, Dhanireddy R. Human milk feedings and infection among very low birth weight infants. Pediatrics 1998;102:e38. - PubMed
Jones 2007
    1. Jones E, Spencer AS. Optimising the provision of human milk for preterm infants. Archives of Diseases of Childhood 2007;92:F236‐F238. - PMC - PubMed
Kramer 2002
    1. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD003517] - DOI - PubMed
Lawrence 1999
    1. Lawrence RA, Lawrence RM. Breast feeding: a Guide for the Medical Profession. St Louis, Missouri: Mosby Incorporated, 1999.
Lucas 1992
    1. Lucas A, Morley R, Cole TJ, Lister G, Leeson‐Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992;339(8788):261‐4. - PubMed
McCarter 2001
    1. McCarter‐Spaulding DE, Kearney MH. Parenting self‐efficacy and perception of insufficient breast milk. Journal of Obstetric, Gynecologic and Neonatal Nursing 2001;30(5):512. - PubMed
McGuire 2003
    1. McGuire W, Anthony MY. Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: a systematic review. Archives of Diseases of Childhood, Fetal and Neonatal Edition 2003;88:F11‐F14. - PMC - PubMed
Ng 2008
    1. Ng E, Shah VS. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD001815.pub2] - DOI - PubMed
NHMRC 2003
    1. National Health and Medical Research Council. Dietary guidelines for children and adolescents: infant feeding guidelines for health workers. Canberra: Australian Government Press, 2003.
Pinder 1976
    1. Pinder RM, Brogden RN, Sawyer PR, Spreight TM, Avery GS. Metoclopramide: A review of its pharmacological properties and clinical use. Drugs 1976;12:81. - PubMed
QPDC 2000
    1. Queensland Perinatal Data Collection. Perinatal Statistics 2000. http://qheps.health.qld.gov.au/hic/peri2000/version2BABY.pdf (accessed 2 February 2004).
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Riordan 1999
    1. Riordan J, Auerbach K. Breastfeeding and Human Lactation. 2nd Edition. Sudbury, Massachusetts: Jones and Bartlett, 1999.
Schanler 1999
    1. Schanler RJ, Schulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999;103:1150‐7. - PubMed
Scott 1999
    1. Scott JA, Binns CW. Factors associated with the initiation and duration of breastfeeding: a review of the literature. Breastfeeding Review 1999;7(1):5‐13. - PubMed
Simic 2004
    1. Simic T, Sumanovic‐Glamuzina D, Boranic M, Vuksic I, Boban A. Breastfeeding practices in Mostar, Bosnia and Herzegovina: cross‐sectional self‐report study. Croatian Medical Journal 2004;45(1):38‐43. - PubMed
WHO 2002
    1. World Health Organization. Infant and Young Child Nutrition: Global Strategy on Infant and Young Child Feeding. 55th World Health Assembly. Geneva: WHO, 2002.

LinkOut - more resources